(WEBINAR) Benzodiazepines: What a clinician should know
CE Type: SW, IACET, APA, CPRP # of CE's: 1.5 CE's 0.2 IACET CE's
About This Course
Benzodiazepines (BZ) are commonly prescribed and used medications. While highly effective in relieving anxiety symptoms, they are also popular drugs of use and abuse. This presentation will equip clinicians with an understanding of the pharmacology of BZ and explore patterns of use, intoxication, and withdrawal syndrome as well as describe clinical skills for assessing a client’s use of BZ, and techniques of working with clients who use BZ. Finally, understanding the challenges of individuals with co-occurring disorder and their use of BZ will be discussed.
- Describe the pharmacologic properties of BZ and how they work.
- Describe BZ intoxication and withdrawal syndromes.
- Describe a method of evaluating an individual who is using BZ.
- Describe an approach to helping clients decrease and stop their BZ use.
Behavioral health staff working in the drug and alcohol field.
Participants must attend the entire session, participate in all activities, and submit an evaluation within the 7 days of training to receive credits and a certificate. All CEU certificates and certificates of attendance will be received through the DBHIDS Learning Hub. Once you have completed your evaluation you will have access to your CEU or Certificate of Attendance through your DBHIDS Learning Hub Account.
BHTEN is accredited by the International Association for Continuing Education and Training (IACET) and is authorized to issue the IACET CEU.
As an IACET Accredited Provider, BHTEN offers CEUs for its programs that qualify under the ANSI/IACET Standard. BHTEN is authorized by IACET to offer CEUs for this program.
(0.2 CEU = 1.5 Training Hours)
1.5 CE credit hours for Psychologists awarded. BHTEN is approved by the American Psychological Association to sponsor continuing education for psychologists. BHTEN maintains responsibility for this program and its content
Behavioral Health Training and Education Network BHTEN, #1779, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards have the final authority on courses accepted for continuing education credit. ACE provider approval period: 9/22/22-9/22/25. Social workers completing this course receive 1.5 General continuing education credits.
The Behavioral Health Training & Education Network (BHTEN), provider #4158280, is approved by Psychiatric Rehabilitation Association (PRA) to provide continuing education to Certified Psychiatric Rehabilitation Practitioners (CPRPs) and CPRP candidates.
This activity is approved for a maximum of 1.5 contact hours of continuing education in psychiatric rehabilitation and recovery in the following CPRP Focus Domain(s): ## - DOMAIN TITLE. CPRPs and CPRP candidates should only claim credit commensurate with their participation in the activity
October 3, 2023
Addiction Recovery Training Specialist
Kay (she/her) is one of BHTEN’s Addiction Recovery Training Specialists. With a history of working in the public sector, non-profits, and community organizing efforts, Kay is experienced in crisis management, substance use response, training implementation, and working with LGBTQIA+ populations. She previously worked with youth and families experiencing chronic or anticipatory homelessness, and adults in substance use recovery and/or active use. Kay is also a harm reduction organizer in Philadelphia and applies a harm reduction framework to her direct practice and systems level work. She received her Master’s in Social Work from the University of Pennsylvania.
March 12, 2024
Pete DeMaria, Jr.
Coordinator of Psychiatric Services
Tuttleman Counseling Services at Temple University
M.D., FASAM, DFAPA
Dr. DeMaria is the coordinator of psychiatric services of the Tuttleman Counseling Services at Temple University in Philadelphia, and clinical professor of psychiatry and behavioral sciences. at the Lewis Katz School of Medicine at Temple University. Prior to coming to Temple, he was the medical director of the Narcotic Addict Rehabilitation Program of Thomas Jefferson University and an associate professor of psychiatry and human behavior at Jefferson Medical College (now the Sidney Kimmel Medical School). He also served as psychiatric consultant at Jefferson’s Family Center Program, a program for addicted pregnant and parenting women. Board certified in general psychiatry, addiction psychiatry, and addiction medicine, Dr. DeMaria is a fellow of the American Society of Addiction Medicine (ASAM). He is a distinguished fellow of the American Psychiatric Association. In October 2001, he received the Nyswander- Dole Award from the American Methadone Treatment Association (now the American Association for the Treatment of Opioid Dependence) for his outstanding service in the methadone treatment field.